2016 PHEMCE Strategy and Implementation Plan
The United States continues to face a range of serious threats to its national health security from the deliberate use or accidental release of chemical, biological, radiological, and nuclear (CBRN) agents, as well as from naturally occurring and emerging infectious diseases (EID), including pandemic influenza.
The 2016 PHEMCE SIP updates the 2014/2015 PHEMCE SIPs and provides the blueprint for the PHEMCE to enhance national health security through the development, procurement and planning for effective use of critical medical countermeasures. The 2016 PHEMCE SIP reflects HHS’s continued commitment, in collaboration with its interagency PHEMCE partners, to provide the nation with a nimble, flexible capacity to rapidly produce and effectively use medical countermeasures in the face of any attack or threat whether known or unknown, novel or reemerging, natural or intentional. The 2016 PHEMCE SIP highlights recent accomplishments, updates our strategic goals and objectives, and identifies priority activities the PHEMCE will implement to advance those strategic goals and objectives.
Information in the 2016 PHEMCE SIP includes:
Information in the 2016 PHEMCE SIP includes:
- Summary of major accomplishments since the 2015 PHEMCE SIP
- Updates to PHEMCE strategic goals and objectives
- Activities being pursued by the PHEMCE agencies
- A summary of PHEMCE interactions with non-federal stakeholders
- Progress in addressing the needs of at-risk populations
- A summary of advanced research and development and procurement awards
- Information regarding the use of funds and authorities originally authorized and provided by the Project BioShield Act of 2004
No hay comentarios:
Publicar un comentario